Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS002 in healthy subjects
NCT04197817Phase 1Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Dec 2017
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hypercholesterolemia comparing JS002 Arm with Placebo Arm (2 arms). Primary endpoint: Adverse Events at 84 days. Started Dec 2017; status: completed.
02
Drugs
ongericimab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04197817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197817.